Dietary Supplement GMP Warning Letters
This article was originally published in The Tan Sheet
Executive Summary
Dietary supplement manufacturers’ responses to FDA reports of good manufacturing practices problems not only are inadequate, but in some instances prompt the agency to warn of checking for corrective actions in later inspections, according to recently posted warning letters.
You may also be interested in...
Food Safety User Fees On Hold Until FDA Creates Waiver Process
Dietary supplement and food product firms will not incur user fees for facility or import re-inspections or mandatory recalls until FDA establishes a waiver process for small businesses.
One-Third Of Supplement GMP Inspections Reveal "Serious Problems" - FDA
About one-third of the 90 dietary supplement good manufacturing practices inspections FDA completed in fiscal 2010 by the start of September revealed serious compliance problems, according to Principal Deputy Commissioner Josh Sharfstein
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”